Comments
Loading...
Quest PharmaTech Analyst Ratings and Price Targets | OTC:QPTFF | Benzinga
Quest PharmaTech Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Quest PharmaTech Corp from these most-recent analyst ratings.
Analyst Ratings for Quest PharmaTech
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Quest PharmaTech (QPTFF) stock?
There is no price target for Quest PharmaTech
What is the most recent analyst rating for Quest PharmaTech (QPTFF)?
There is no analyst for Quest PharmaTech
When was the last upgrade for Quest PharmaTech (QPTFF)?
There is no last upgrade for Quest PharmaTech
When was the last downgrade for Quest PharmaTech (QPTFF)?
There is no last downgrade for Quest PharmaTech.
When is the next analyst rating going to be posted or updated for Quest PharmaTech (QPTFF)?
There is no next analyst rating for Quest PharmaTech.
Is the Analyst Rating Quest PharmaTech (QPTFF) correct?
There is no next analyst rating for Quest PharmaTech.
Browse analyst ratings and price targets on all stocks.
